Biogen Pharma

{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.53",
    "chg": 0.01,
    "chgp": "1.92%",
    "dir": 1,
    "prev_price": "0.52",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE703D01023",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": "22.67 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3900304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiogenPharmache_mojoScore_3900304.png",
        "date": "2026-03-19 10:10:20",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 March 2026, providing investors with the latest insights into its performance and valuation."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs05-3899941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiogenPharmache_priceRelatedfactors_3899941.png",
        "date": "2026-03-19 09:47:09",
        "description": "Biogen Pharmachem Industries Ltd has touched a new 52-week low today, closing at Rs.0.5, marking a significant decline in its share price amid a challenging market environment and subdued financial performance."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-amidst-continued-downtrend-3893923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiogenPharmache_priceRelatedfactors_3893923.png",
        "date": "2026-03-16 12:13:36",
        "description": "Biogen Pharmachem Industries Ltd has declined to a fresh 52-week low of Rs.0.55, marking a significant downturn in its stock performance amid a challenging market environment and subdued financial indicators."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3873194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BiogenPharmache_mojoScore_3873194.png",
        "date": "2026-03-05 10:10:20",
        "description": "Biogen Pharmachem Industries Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3850515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiogenPharmache_mojoScore_3850515.png",
        "date": "2026-02-22 10:10:29",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Are Biogen Pharmachem Industries Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-biogen-pharmachem-industries-ltd-latest-results-good-or-bad-3835715",
        "imagepath": "",
        "date": "2026-02-12 19:47:21",
        "description": "Biogen Pharmachem Industries Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape. The company reported a net profit of ₹0.46 crores, marking a return to profitability after a loss of ₹0.49 crores in the previous quarter. This turnaround is notable when compared to the ₹0.31 crores loss in Q3 FY25, indicating a sequential improvement and a year-on-year recovery. However, it is essential to recognize that this profit was largely influenced by other income of ₹0.54 crores, as the company continues to grapple with zero operating revenue, having reported no net sales for the past seven quarters.\n\nThe nine-month period ending December 2025 also showed a cumulative net profit of ₹1.31 crores, a significant recovery from a loss of ₹1.47 crores in the same period the previous year. Despite these positive figures, the underlying operational challenges remain concerning, particularly the..."
      },
      {
        "title": "Biogen Pharmachem Industries Q3 FY26: Profitability Returns Amid Volatile Trajectory",
        "link": "https://www.marketsmojo.com/news/result-analysis/biogen-pharmachem-industries-q3-fy26-profitability-returns-amid-volatile-trajectory-3833664",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiogenPharmache_quaterlyResult_3833664.png",
        "date": "2026-02-11 18:31:17",
        "description": "Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹62.00 crores, has reported a return to profitability in Q3 FY26 (October-December 2025) after a loss-making previous quarter. The company posted a net profit of ₹0.46 crores for the quarter ended December 2025, marking a sharp turnaround from a loss of ₹0.49 crores in Q2 FY26. However, the stock continues to face significant headwinds, trading at ₹0.69 and down 34.91% over the past year, significantly underperforming both the Sensex and its NBFC sector peers."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3830524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiogenPharmache_mojoScore_3830524.png",
        "date": "2026-02-10 10:10:25",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Biogen Pharmachem Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biogen-pharmachem-industries-ltd-3821230",
        "imagepath": "",
        "date": "2026-02-04 23:17:08",
        "description": "The next results date for Biogen Pharmachem Industries Ltd is scheduled for 11 February 2026...."
      }
    ],
    "total": 77,
    "sid": "200854",
    "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "25-Mar-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Clarification For Point No 4 Of The Outcome In Reference To The Outcome Uploaded Of The Board Meeting Held On 23Rd March 2026.",
      "datetime": "24-Mar-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd March 2026",
      "datetime": "23-Mar-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Monday 23rd March 2026 at the Registered Office of the Company and transacted the major businesses which are attached in pdf. The board meeting commented at 07:00 PM and concluded at 07:30 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-03-19 10:10:20

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 March 2026, providing investors with the latest insights into its performance and valuation.

Read full news article

Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.5

2026-03-19 09:47:09

Biogen Pharmachem Industries Ltd has touched a new 52-week low today, closing at Rs.0.5, marking a significant decline in its share price amid a challenging market environment and subdued financial performance.

Read full news article

Biogen Pharmachem Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-03-16 12:13:36

Biogen Pharmachem Industries Ltd has declined to a fresh 52-week low of Rs.0.55, marking a significant downturn in its stock performance amid a challenging market environment and subdued financial indicators.

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-03-05 10:10:20

Biogen Pharmachem Industries Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 05 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-02-22 10:10:29

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Are Biogen Pharmachem Industries Ltd latest results good or bad?

2026-02-12 19:47:21

Biogen Pharmachem Industries Ltd's latest financial results for Q3 FY26 reflect a complex operational landscape. The company reported a net profit of ₹0.46 crores, marking a return to profitability after a loss of ₹0.49 crores in the previous quarter. This turnaround is notable when compared to the ₹0.31 crores loss in Q3 FY25, indicating a sequential improvement and a year-on-year recovery. However, it is essential to recognize that this profit was largely influenced by other income of ₹0.54 crores, as the company continues to grapple with zero operating revenue, having reported no net sales for the past seven quarters. The nine-month period ending December 2025 also showed a cumulative net profit of ₹1.31 crores, a significant recovery from a loss of ₹1.47 crores in the same period the previous year. Despite these positive figures, the underlying operational challenges remain concerning, particularly the...

Read full news article

Biogen Pharmachem Industries Q3 FY26: Profitability Returns Amid Volatile Trajectory

2026-02-11 18:31:17

Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹62.00 crores, has reported a return to profitability in Q3 FY26 (October-December 2025) after a loss-making previous quarter. The company posted a net profit of ₹0.46 crores for the quarter ended December 2025, marking a sharp turnaround from a loss of ₹0.49 crores in Q2 FY26. However, the stock continues to face significant headwinds, trading at ₹0.69 and down 34.91% over the past year, significantly underperforming both the Sensex and its NBFC sector peers.

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-02-10 10:10:25

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Biogen Pharmachem Industries Ltd?

2026-02-04 23:17:08

The next results date for Biogen Pharmachem Industries Ltd is scheduled for 11 February 2026....

Read full news article

View All News